Mode of delivery, mechanism of action, and efficacy of a novel treatment are discussed in this research update.
The FDA has approved a new drug for the prevention of migraines. Will the injectable treatment help reduce the number of days of migraine headaches?
Because of the increased incidence of stroke that is sometimes observed with HRT, neurologists are often asked to consult with prescribing physicians to assess stroke risk.
What are the key symptoms of TIND, a rare condition that can occur after rapid normalization of blood glucose levels following prolonged periods of hyperglycemia?
Psychosis symptoms in patients with Parkinson disease can turn a difficult situation into an untenable one: they are the leading reason that patients leave their homes for continued care in a skilled nursing facility.
How effective is the telemedicine versus telephonic approach in acute care?
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
Are AEDs safe for children? Take the quiz and learn more.
A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.
New treatments for MG may have a more direct effect on the action of acetylcholine on the neuromuscular junction than steroids, IVIG, and plasmaphoresis.
An update on the prevalence and features of demoralization in patients with PD.
New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.
5 key facts about cerebral microbleeds and risk of future cognitive impairment.
While migraine is distinct from stroke in its gradual onset and lack of focal motor weakness, it is also a predisposing factor for childhood stroke. That can raise the question, “Is it another migraine or is it actually stroke this time?”
With approximately 500 board-certified headache specialists and just over 60 million Americans with headache, the average wait time to see one of us is 3 to 4 months. Technology may hold the key to issues such as this.